Used in the synthesis of radiopharmaceuticals for positron emission tomography (PET) imaging due to the presence of iodine, which can be labeled with radioactive isotopes such as iodine-124 or iodine-131. Its chiral structure makes it suitable as a building block in the development of targeted imaging agents and therapeutic compounds, particularly in neuroscience and oncology research. The compound’s hydroxyl and amino groups allow for easy functionalization, enabling conjugation to larger biomolecules or integration into more complex molecular frameworks.